MBCL-03. RESULTS OF HIGH-DOSE THIOTEPA, CARBOPLATIN AND ETOPOSIDE WITH AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION FOR PATIENTS WITH RECURRENT MEDULLOBLASTOMA

AIM: Medulloblastoma is a highly lethal disease when it recurs. Very few patients survive with second line conventional treatment after relapse. This study evaluated the use of high-dose thiotepa, carboplatin and etoposide with autologous hematopoietic stem-cell transplantation (HSCT) in patients wi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuro Oncol
Hauptverfasser: Gevorgian, Asmik, Tolkunova, Polina, Kazantsev, Ilya, Iukhta, Tatiana, Kozlov, Andrew, Zvyagintseva, Darya, Morozova, Elena, Zubarovskaya, Ludmila, Afanasiev, Boris, Zheludkova, Olga, Punanov, Yury
Format: Artigo
Sprache:Inglês
Veröffentlicht: Oxford University Press 2020
Schlagworte:
Medulloblastoma (Clinical)
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7715147/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa222.479
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge